作者：
Daniel L,Hertz [1]
;
Kouros,Owzar [2]
;
Sherrie,Lessans [3]
;
Claudia,Wing [4]
;
Chen,Jiang [5]
;
William Kevin,Kelly [6]
;
Jai,Patel [7]
;
Susan,Halabi [2]
;
Yoichi,Furukawa [8]
;
Heather E,Wheeler [4]
;
Alexander B,Sibley [9]
;
Cameron,Lassiter [3]
;
Lois,Weisman [10]
;
Dorothy,Watson [5]
;
Stefanie D,Krens [11]
;
Flora,Mulkey [5]
;
Cynthia L,Renn [3]
;
Eric J,Small [12]
;
Phillip G,Febbo [13]
;
Ivo,Shterev [14]
;
Deanna L,Kroetz [15]
;
Paula N,Friedman [4]
;
John F,Mahoney [16]
;
Michael A,Carducci [17]
;
Michael J,Kelley [18]
;
Yusuke,Nakamura [19]
;
Michiaki,Kubo [20]
;
Susan G,Dorsey [3]
;
M Eileen,Dolan [4]
;
Michael J,Morris [21]
;
Mark J,Ratain [4]
;
Howard L,McLeod [22]
作者单位：
Department of Clinical Pharmacy, University of Michigan College of Pharmacy, Ann Arbor, Michigan. UNC Institute for Pharmacogenomics and Individualized Therapy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
[1]
Duke Cancer Institute, Durham, North Carolina. Alliance Statistics and Data Center, Duke University, Durham, North Carolina.
[2]
Department of Pain and Translational Symptom Science, University of Maryland School of Nursing, Baltimore, Maryland.
[3]
Department of Medicine, University of Chicago, Chicago, Illinois.
[4]
Alliance Statistics and Data Center, Duke University, Durham, North Carolina.
[5]
Thomas Jefferson University, Philadelphia, Pennsylvania.
[6]
UNC Institute for Pharmacogenomics and Individualized Therapy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina. Levine Cancer Institute, Carolinas HealthCare System, Charlotte, North Carolina.
[7]
Division of Clinical Genome Research, Advanced Clinical Research Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
[8]
Duke Cancer Institute, Durham, North Carolina.
[9]
Life Sciences Institute, University of Michigan, Ann Arbor, Michigan.
[10]
UNC Institute for Pharmacogenomics and Individualized Therapy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina. Utrecht University, Faculty of Science, Department of Pharmaceutical Sciences, Utrecht, the Netherlands.
[11]
Department of Medicine, UCSF, San Francisco, California.
[12]
Genomic Health, Redwood City, California.
[13]
Department of Biostatistics and Bioinformatics, Duke University, Durham, North Carolina.
[14]
Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, California.
[15]
Levine Cancer Institute, Carolinas HealthCare System, Charlotte, North Carolina.
[16]
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, Maryland.
[17]
Durham VA Medical Center, Duke University Medical Center, Durham, North Carolina.
[18]
Department of Medicine, University of Chicago, Chicago, Illinois. Division of Clinical Genome Research, Advanced Clinical Research Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
[19]
Lab for Genotyping Development, Riken Center for Integrative Medical Sciences, Kanagawa, Japan.
[20]
Memorial Sloan Kettering Cancer Center, New York.
[21]
UNC Institute for Pharmacogenomics and Individualized Therapy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina. Personalized Medicine Institute, Moffitt Cancer Center, Tampa, Florida. Howard.mcleod@moffitt.org.
[22]
DOI
10.1158/1078-0432.CCR-15-2823
PMID
27143689
发布时间
2021-12-21
换一批
换一批
